PRAX
Praxis Precision Medicines Inc
NASDAQ: PRAX · HEALTHCARE · BIOTECHNOLOGY
$323.19
+0.39% today
Updated 2026-04-29
Market cap
$9.00B
P/E ratio
—
P/S ratio
953.14x
EPS (TTM)
$-13.47
Dividend yield
—
52W range
$35 – $356
Volume
0.4M
Praxis Precision Medicines Inc (PRAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-45.80%
ROA
-28.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-26.54M | — | — | — |
| 2019 | $0.00 | $-35.51M | — | — | — |
| 2020 | $0.00 | $-61.82M | — | — | — |
| 2021 | $0.00 | $-166.88M | — | — | — |
| 2022 | $1.46M | $-213.07M | -79.99% | -14,684.84% | -14,554.10% |
| 2023 | $2.45M | $-123.28M | -3,445.81% | -5,164.41% | -5,037.88% |
| 2024 | $8.55M | $-182.82M | -1,681.98% | -2,340.29% | -2,137.48% |
| 2025 | $0.00 | $-303.27M | — | — | — |